Table 1.
Expression of miR-1269 in samples from patients with lung cancer and its relationship with clinical pathological parameters
Characteristics | Number of patients | miR-1269 high expression | miR-1269 low expression | P-value |
---|---|---|---|---|
Patients (n) | 52 | 37 | 15 | |
Age (years) | 0.490 | |||
≤60 | 33 | 24 | 9 | |
>60 | 19 | 13 | 6 | |
Gender | 0.399 | |||
Male | 28 | 19 | 9 | |
Female | 24 | 18 | 6 | |
Tumor size (cm) | 0.501 | |||
≤3.0 | 19 | 14 | 5 | |
>3.0 | 33 | 23 | 10 | |
Histology | 0.571 | |||
Adenocarcinoma | 27 | 19 | 8 | |
Squamous carcinoma | 25 | 18 | 7 | |
Tumor stage | 0.022* | |||
I | 10 | 10 | 0 | |
II | 23 | 14 | 9 | |
IIIa | 19 | 13 | 6 | |
Lymph node metastasis | 0.044* | |||
No | 20 | 11 | 9 | |
Yes | 32 | 26 | 6 |
Note:
P<0.05.